Mammary Dysbiosis
Author:
- 1 August 2018
- journal article
- Published by Springer Publishing Company in Clinical Lactation
- Vol. 9 (3) , 130-136
Abstract
Mastitis can be an unwelcome and debilitating visitor to breastfeeding mothers. The mammary gland has its own microbiome that can be affected by reduced polymorphonuclear neutrophil recruitment during the first 3 months postpartum, as well as the receipt of antibiotics during the last trimester of pregnancy. This can leave the breast vulnerable to pathologic bacterial overgrowth. Mammary dysbiosis is a process whereby the population of potential pathogens increases at the expense of the normal mammary microbiota. Multiresistance to antibiotics plus tricky evasion techniques engaged in by bacterial agents can result in microbes that are elusive to antibiotic therapy. Therefore, new strategies are needed for the treatment of this threat to continued breastfeeding. Bacteriotherapy, targeting harmless bacteria to displace pathologic organisms, is an emerging therapeutic intervention that uses probiotics instead of antibiotics. Once more high-quality clinical trials of strain-specific probiotics have been conducted, bacteriotherapy may move into mainstream mastitis treatment.Keywords
This publication has 26 references indexed in Scilit:
- The microbiology and treatment of human mastitisMedical Microbiology and Immunology, 2018
- Probiotics and mastitis: evidence-based marketing?International Breastfeeding Journal, 2016
- Determinants of mastitis in women in the CASTLE study: a cohort studyBMC Family Practice, 2015
- Prevention of Infectious Mastitis by Oral Administration ofLactobacillus salivariusPS2 During Late PregnancyClinical Infectious Diseases, 2015
- Effectiveness of Topical Curcumin for Treatment of Mastitis in Breastfeeding Women: A Randomized, Double-Blind, Placebo-Controlled Clinical TrialOman Medical Journal, 2014
- Probiotics in human milk and probiotic supplementation in infant nutrition: a workshop reportBritish Journal of Nutrition, 2014
- ABM Clinical Protocol #4: Mastitis, Revised March 2014Breastfeeding Medicine, 2014
- Probiotics for human lactational mastitisBeneficial Microbes, 2014
- Characterization ofStaphylococcus aureusstrains involved in human and bovine mastitisFEMS Immunology & Medical Microbiology, 2011
- The Bacteriocin Nisin, an Effective Agent for the Treatment of Staphylococcal Mastitis During LactationJournal of Human Lactation, 2008